A. Mpouhla

Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study

A. Hatzakis, M. Psichogiou, V. Pappa, 2022, Therapeutic advances in hematology.

Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection

A. Hatzakis, V. Pappa, M. Psichogiou, 2022, Annals of Hematology.